Easier said than done but India should buy Chinese Covid-19 vaccines

There cannot be a bigger national interest right now than saving Indians from avoidable death.

India’s vaccine strategy has flopped. A dismissive attitude toward the second Covid-19 outbreak that has raged uncontrolled, and a mistaken belief that indigenously made shots would be equal to the task of inoculating a billion adults, have left the nation scrambling. Efforts are under way to procure supplies from Pfizer Inc., Moderna Inc. and Johnson & Johnson. But their order books are full. 

There is a way out of the crunch, as long as authorities are realistic: acquiring vaccines from regional rival China. They don’t have the same efficacy as the leading-edge products and may not offer a ticket to herd